AMR Action Fund

ICYMI, IDSA released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs). The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs. View guidelines: bit.ly/4lUjN1a

"If selling antibiotics loses money, no one will invest.” CEO Henry Skinner recently discussed with @swissinfo_en why private investors have turned away from antibiotics and how pull incentives could help bring them back. swissinfo.ch/eng/new-treatm…

The potential economic consequences of #AMR are staggering. A new piece from The Guardian notes that superbugs could cost the global economy just under $2tn a year by 2050 theguardian.com/society/2025/j…

New study led by Public Health Agency of Canada shows incidence of Carbapenemase-producing Enterobacterales is accelerating at an exponential rate, driven by nosocomial transmission. aricjournal.biomedcentral.com/articles/10.11… #AMR

Interested in how #AMR intersects with #cancer and other #NCDs and what can be done to reduce the risk? Then check out this WHO Taskforce of AMR Survivors webinar on Thursday. Register here who.zoom.us/webinar/regist…

"It is no exaggeration when I say that antibiotics have helped nearly every cancer patient whom I have successfully cared for during their hospital admission for complications of their cancer or treatment." #AMR #Cancer statnews.com/2025/07/16/can…

When a company goes bankrupt or into administration, the worst-case scenario for an asset-in-development is that it “goes into the trash bin of history,” says Henry Skinner, CEO of the AMR Action Fund #AMR bloomberg.com/news/newslette…

Infections from flesh-eating bacteria have now killed 4 ppl in #Florida. Last year, CEO Henry Skinner examined the record-breaking # of vibrio v cases and offered suggestions on how to better prepare for these outbreaks harvardpublichealth.org/policy-practic…

"Without effective antibiotics, we’ll never fully reap the benefits of immunotherapies, precision medicines, and other recent advances in cancer care." statnews.com/2025/07/16/can… #AMR #Cancer

We issued an #RFP under Project BioShield to support advanced development and potential procurement of an antibiotic to treat bloodstream infections or hospital-acquired or ventilator-associated pneumonia caused by #AMR bacteria. Apply by August 26, 2025: ow.ly/pvWj50Wqf2T

In a recent interview with @InnoNewsNetwork, #AMR Action Fund CEO Henry Skinner discussed how incentives that reward the successful development of urgently needed antibiotics will rekindle private investment and benefit patients who are suffering from intractable infections.

“If a wealthy country like Switzerland doesn’t join international efforts to create reimbursement models for new antibiotics, this will not send an encouraging signal to other countries and investors,” said Barbara Polek swissinfo.ch/eng/new-treatm… #AMR

"Antimicrobial resistance disproportionately impacts patients with cancer, because many have weakened immune systems that make them completely reliant on effective antibiotics," said Michael Satlin of Weill Cornell forbes.com/sites/juergene… #cancer #AMR h/t @LeapsByBayer

"As resistant infections have emerged in recent decades, doctors have been forced to reach back in time and rely on very old antibiotics that can have some nasty side effects. Patients deserve better." #AMR via @InnoNewsNetwork innovationnewsnetwork.com/amr-action-fun…

An illuminating article on why Switzerland should incentivize antibiotic R&D and ensure access to advanced antibiotics. As one doctor says "More and more antibiotics needed for treating patients aren’t licensed here and must be imported" #AMR swissinfo.ch/eng/new-treatm…